“Although there has been some progress with the release of some detainees and the development of a national human rights strategy, Egypt persists in routinely misusing counter-terrorism legislation ...
Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the supplemental New Drug Application for ORPATHYS ® (savolitinib) has been granted approval by the China National Medical ...
This ranking from EcoVadis reflects our progress and motivates us to continue striving for greater impact.” Telia’s 2024 sustainability efforts will be further detailed in its Annual Report, due for ...